If you need more lookups,
subscriptions start at $34 USD/month.
Rob Barker Location
London, England, GB
Rob Barker Work
Chairman @ (February 2026 - Present)
Resting @ Resting (August 2024 - April 2026)
Group Chief Executive Officer @ (November 2020 - August 2024)
CEO - Communications Practice @ (September 2015 - November 2020)
Managing Director - London @ (July 2014 - September 2015)
European Managing Director APO Group @ (January 2013 - June 2014)
Founding Partner @ The Central Group (April 2004 - December 2012)
Managing Director @ Medicus International (June 2001 - April 2004)
Managing Director @ (July 1999 - May 2001)
Global Commercial Lead: Anti-Infectives @ (September 1995 - October 1999)
Product Manager @ (September 1991 - August 1995)
Rob Barker Education
School of Business and Law, University of Brighton
Master of Business Administration (MBA) (Business Administration and Management, General)
1993-1995
Brighton School of Pharmacy
BSc (Pharmacy)
1988-1991
Bedford Modern School
Rob Barker Skills
Integrated Marketing
Management
Marketing
Medical Education
Pharmaceutical Industry
Oncology
Market Access
Marketing Strategy
Diabetes
Strategy
Marketing Communications
Digital Marketing
Product Launch
Advisory Boards
Digital Strategy
Strategic Planning
Hospital Sales
Pharmaceutical Sales
Brand Development
Global Marketing
Healthcare
Satisfied Clients
Pharmaceutical Companies
Rob Barker Summary
Rob Barker, based in London, England, GB, is currently a Chairman at Coronado Research. Rob Barker brings experience from previous roles at Resting, OPEN Health and OPEN Health Medical Communications. Rob Barker holds a 1993 - 1995 Master of Business Administration (MBA) in Business Administration and Management, General @ School of Business and Law, University of Brighton. With a robust skill set that includes Integrated Marketing, Management, Marketing, Medical Education, Pharmaceutical Industry and more. Rob Barker has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Rob Barker?
Find contact details for 700 million professionals.